PeptiDream Inc. (TYO:4587)

Market Cap	154.60B -41.8%
Revenue (ttm)	18.52B -60.3%
Net Income	-3.75B
EPS	-28.99
Shares Out	129.21M
PE Ratio	n/a
Forward PE	11.76
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,495,400
Average Volume	1,393,060
Open	1,135.00
Previous Close	1,151.00
Day's Range	1,135.00 - 1,198.50
52-Week Range	1,131.50 - 2,223.50
Beta	0.04
RSI	35.63
Earnings Date	May 12, 2026

About PeptiDream

PeptiDream Inc., a biopharmaceutical company, engages in the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics. The company develops its products based on its Peptide Discovery Platform System, a drug finding platform that enables the production of non-standard peptide libraries for the identification of potent and selective macrocyclic peptide candidates, which then can be developed into peptide-based, small molecule-based, peptide-drug conjugate, and multi-functional peptide conjugates...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2006
• Employees: 751
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4587